Home
    Scientific Program
    Registration
    Accommodation
    Contact
The 2nd International Congress on
Controversies in Cryopreservation of Stem Cells, Reproductive Cells, Tissue & Organs (CRYO)
Palacio de Congresos, Valencia, Spain, April 7-9, 2011
 
  Scientific Program Print
FRIDAY, APRIL 8, 2011                  Auditorium 3
    
Session 1
09:00-11:00  New Approaches in Cryopreservation: Vitrification
     
Chairpersons    A. Arav, Israel; G. Vajta, Australia
   
09:00-09:30
 Controlled stress to improve cryotolerance
 C. Pribenszky, Hungary
 
09:30-10:00
 Mechanisms and Practical Applications of Kinetic (High-Speed) Vitrification
 I. Katkov, USA
 
10:00-10:30
 Small drop Vitrification
 U. Dimirici, USA
  
10:30-11:00
 Q&A
 
   
11:00-11:30  Coffee Break
     
    
Session 2  
11:30-13:00  Vitrification
   
Chairpersons   A. Dinnyes, Hungary;  S. Leibo, USA
   
11:30-12:00
 Vitrification approaches: Should we agree to disagree?
 G. Vajta, Australia
  
12:00-12:30
 Vitrification of pluripotent stem cells and their derivatives
 A. Dinnyes, Hungary
  
12:30-13:00
 The optimal Vitrification
 A. Arav, Israel
  
   
13:00-14:00  Lunch Break
   
     
Session 3  
14:00-16:00  Cryo Banking
   
Chairpersons    P. Loi, Italy; P. Patrizio, USA
   
14:00-14:30
 Embryos banking
 S. Leibo, USA
    
14:30-15:00
 Oocytes banking
 A. Cobo, Spain
 
15:00-15:30
 Sperm banking
 J. Saragusty,Germany 
 
15:30-16:00
 Q&A
  
     
16:00-16:30  Coffee Break
   
   
Session 4  
16:30-18:00
 Ethics and Social Consequences of Electively Deferring Motherhood through
 Oocyte Cryopreservation
   
Chairpersons    S. Mashiach, Israel; Z. Shoham, Israel; G. Vajta, Australia
   
16:30-17:00
 Social egg freezing - What are the limits?
 N. Noyes, USA
 
17:00-17:30
 The consequences of encouraging the delay of motherhood for social reasons are
 entirely positive
 G. Lockwood, UK
  
17:30-18:00
   
SATURDAY, APRIL 9, 2011                         Auditorium 3
  
    
Session 5  
09:00-10:40  Stem Cells
   
Chairperson     I. Katkov, USA
   
09:00-09:25
 Guidance for banking and supply of human embryonic stem cell lines for research
 purposes 
 C. Simón, Spain
  
09:25:09:45
 Freezing human pluripotent stem cells in fully dissociated (suspensions) and
 adherent (test plates) states
 I. Katkov, USA 
   
09:45-10:05
 Advances in and novel approaches to cryopreservation of encapsulated stem cells
 and neurospheres
 R. Malpique, Portugal
 
10:05-10:30
 Perspectives of stem cell derived gametes
 K. Nayernia, Germany
 
10:30-10:40
 Q&A
   
    
10:40-11:00
 Coffee Break
   
   
Session 6  
11:00-13:00  Fertility preservation: New strategies
 
Chairpersons    J. Donnez, Belgium; A. Pellicer, Spain
   
11:00-11:30  Outcome of cortical graftings
 
 J. Donnez, Belguim 
   
11:30-12:00
 Experience of in vitro perfusion to evaluate cryopreserved ovine and human ovaries
 M. Brännström, Sweden

   
12:00-12:30
 In vitro folliculogenesis
 P. Patrizio, USA
   
12:30-13:00
The forefront of clinical ovarian tissue vitrification
N. Kagawa, Japan
   
   
13:00-14:00  Lunch Break
   
   
Session 7  
14:00-15:30  Oocyte Vitrification
       
Chairpersons      A. Cobo, Spain; N. Noyes, USA
       
14:00-14:20
 Vitrification of IVM Oocytes
 W.Y. Son, Canada
      
14:20-14:40
 Freeze Drying Oocytes
 P. Loi, Italy
     
14:40-15:00
 Clinical application of oocyte vitrification for infertile patients
 L. Rienzi, Italy
    
15:00-15:15
15:15-15:30
       
15:30-16:00  Coffee Break
       
   
Session 8  
16:00-18:00  Vitrification of Embryos: From Research to clinical Application
   
Chairpersons    A. Arav, Israel; J. Liebermann, USA
   
16:00-16:30
 Time lapse analysis of mice zygotes exposed to cryoprotectant solutions: an  
 approach to observe and understand the behavior of cells during a vitrification
 process
 B. Wirleitner, Austria
  
16:30-17:00
 Vitrification of cleavage stage embryos: From clinical application to healthy live  
 births
 G. A. Rama Raju, India
 
17:00-17:30
 Does opening of Zona Pellucida prior to Trophectoderm biopsy have adverse 
 effects for successful vitrification of blastocysts? 
 B. Wirleitner, Austria
 
17:30-18:00
Data on more than 4000 transferred vitrified human blastocysts: Successful switch from an open to a closed system
J. Liebermann, USA

 
   

Home   
Copyright © 2007 Comtecmed.com. All rights reserved.   The website was last updated on 05/01/2011 Created by    WebStudio.co.il